INNOVATIVE MANAGEMENT OF HERPETIC STOMATITIS IN CHILDREN: CLINICAL PERSPECTIVES FROM ITALY

Main Article Content

Prof. Lorenzo Bianchi

Abstract

Herpetic stomatitis is one of the most common viral diseases affecting the oral cavity in children, mainly caused by Herpes simplex virus type 1 (HSV-1). The condition is characterized by fever, gingival inflammation, painful oral vesicles, ulcerations, feeding difficulties, irritability, and temporary reduction in quality of life. Although the disease is often self-limiting, severe cases may result in dehydration, secondary infection, and hospitalization. Conventional treatment includes antiviral medication, hydration therapy, pain management, and oral hygiene support. However, recent developments in pediatric dentistry and oral medicine in Europe have introduced innovative strategies aimed at faster healing, reduced discomfort, improved immune response, and lower recurrence rates. These include photobiomodulation therapy, regenerative oral biomaterials, microbiome-based interventions, nanotechnology drug delivery systems, telemedicine monitoring, and personalized pediatric care pathways. This article reviews modern approaches to the treatment of herpetic stomatitis in children, with emphasis on practical application within advanced healthcare systems such as Italy. The findings indicate that integrated multimodal management can significantly improve clinical outcomes and patient comfort.


 

Article Details

Section
Articles

References

Arduino PG, Porter SR. Oral herpes simplex infections.

Amir J et al. Acyclovir in primary herpetic gingivostomatitis.

Greenberg MS. Burket’s Oral Medicine.

Neville BW et al. Oral and Maxillofacial Pathology.

European Academy of Pediatric Dentistry clinical guidance.